Differences in how cells respond to rejuvenation raise doubts about whole-body approaches, says aging researcher de Magalhães
Differences in how cells respond to rejuvenation raise doubts about whole-body approaches, says aging researcher de Magalhães
On November 13, aging researcher João Pedro de Magalhães commented on experiments by Shinya Yamanaka’s group involving human skin, blood vessel, and immune cells. Reductions in molecular age, estimated from chemical marks on DNA, did not consistently coincide with improvements in cell function. Yuri Deigin, co-founder of the biotechnology company YouthBio Therapeutics, saw the same study as support for a strategy of targeting tissues separately.
Four proteins known as the Yamanaka factors can return an adult cell to a stem cell state. This reduces several signs of aging, but the cell loses its specialized identity. Partial reprogramming aims to stop this process at a point that allows the cell to resume its function while retaining beneficial changes. In experiments in 2022, human skin cells had already been shown to regain their specialized identity after the factors were withdrawn, while retaining a lower molecular age. The researchers have now examined how far different cells can progress through reprogramming and still recover.
A preprint dated November 12 compared three types of human cells grown in the laboratory, each obtained from four donors aged 48–63 years. Skin cells are commonly used in reprogramming experiments; the other two types were chosen to explore ways to improve immune defenses and the function of aging blood vessels. Different cell types progressed through reprogramming at different rates over the same period. The researchers therefore grouped cells within each type by how far they had progressed: how much of their original identity they had lost and how closely they resembled stem cells. They then switched off the factors and assessed recovery, age estimated from DNA marks, and cell function, comparing the results with cells in which the factors had not been activated.
Fibroblasts, the cells that produce the skin’s connective tissue, retained a lower estimated age after extensive reprogramming. However, cells in the most extensively reprogrammed group proliferated less well and closed a scratch in the cell layer more slowly. Killer T cells, which destroy infected and tumor cells, proliferated better after limited reprogramming, although the initial reduction in molecular age disappeared. Upon stimulation, they released more interferon-gamma, which enhances the immune response, and perforin, which forms pores in the target cell’s membrane. More extensive reprogramming left T cells unable to sustain proliferation.
Cells lining the aorta showed both effects: they retained a lower estimated age and formed vessel-like networks more effectively in a laboratory assay, even after accounting for cell number. For each cell type, molecular age and the recovery of function after reprogramming was stopped had to be assessed separately.
These differences led de Magalhães to question the “feasibility of whole-body rejuvenation approaches.” Deigin described the need to tailor interventions to specific tissues and cells as “YouthBio’s core principle from day one”. De Magalhães himself leads the science at YouthBio: two leaders of the same company interpret the significance of the findings differently.
In an interview in 2022, Deigin had already proposed choosing different factors and activation schedules for different organs. The company now plans to combine separate interventions to rejuvenate several organs. It aims to rejuvenate the body by targeting tissues separately; for each tissue, researchers still need to determine when to stop reprogramming and verify that function recovers.
- https://doi.org/10.7554/eLife.71624
- https://www.biorxiv.org/content/10.64898/2026.11.09.764947v1
- https://x.com/jpsenescence/status/2121333419695387068
- https://x.com/ydeigin/status/2121336985037992214
- https://youthbiotx.com/team
- https://www.lifespan.io/news/yuri-deigin-on-cellular-reprogramming-in-humans/
- https://youthbiotx.com/about